5R01AG062309-04 |
2022 |
$694721 |
Early life glycemic status and Alzheimer's disease neuroimaging markers in middle age: the Bogalusa Heart Study |
5R01AG062309-03 |
2021 |
$714363 |
Early life glycemic status and Alzheimer's disease neuroimaging markers in middle age: the Bogalusa Heart Study |
5R01AG062309-02 |
2020 |
$722108 |
Early life glycemic status and Alzheimer's disease neuroimaging markers in middle age: the Bogalusa Heart Study |
3R01AG062309-02S1 |
2020 |
$310085 |
Supplemental Funding Request for RF1 AG062309 Early life glycemic status and Alzheimer's disease neuroimaging markers in middle age: the Bogalusa Heart Study |
1R01AG062309-01 |
2019 |
$721323 |
Early life glycemic status and Alzheimer's disease neuroimaging markers in middle age: the Bogalusa Heart Study |